1178 related articles for article (PubMed ID: 23663741)
21. Fibroblast growth factor-21 (FGF21) administration to early-lactating dairy cows. I. Effects on signaling and indices of insulin action.
Krumm CS; Giesy SL; Caixeta LS; Perfield JW; Sauerwein H; Moore BL; Boisclair YR
J Dairy Sci; 2019 Dec; 102(12):11586-11596. PubMed ID: 31548053
[TBL] [Abstract][Full Text] [Related]
22. Probiotic culture supernatant improves metabolic function through FGF21-adiponectin pathway in mice.
Liu Q; Liu Y; Li F; Gu Z; Liu M; Shao T; Zhang L; Zhou G; Pan C; He L; Cai J; Zhang X; Barve S; McClain CJ; Chen Y; Feng W
J Nutr Biochem; 2020 Jan; 75():108256. PubMed ID: 31760308
[TBL] [Abstract][Full Text] [Related]
23. DEPP/DEPP1/C10ORF10 regulates hepatic glucose and fat metabolism partly via ROS-induced FGF21.
Li W; Ji M; Lin Y; Miao Y; Chen S; Li H
FASEB J; 2018 Oct; 32(10):5459-5469. PubMed ID: 29702025
[TBL] [Abstract][Full Text] [Related]
24. The FGF21-adiponectin axis in controlling energy and vascular homeostasis.
Hui X; Feng T; Liu Q; Gao Y; Xu A
J Mol Cell Biol; 2016 Apr; 8(2):110-9. PubMed ID: 26993043
[TBL] [Abstract][Full Text] [Related]
25. Selective activation of PPARgamma in skeletal muscle induces endogenous production of adiponectin and protects mice from diet-induced insulin resistance.
Amin RH; Mathews ST; Camp HS; Ding L; Leff T
Am J Physiol Endocrinol Metab; 2010 Jan; 298(1):E28-37. PubMed ID: 19843873
[TBL] [Abstract][Full Text] [Related]
26. FGF21-FGFR1 Coordinates Phospholipid Homeostasis, Lipid Droplet Function, and ER Stress in Obesity.
Ye M; Lu W; Wang X; Wang C; Abbruzzese JL; Liang G; Li X; Luo Y
Endocrinology; 2016 Dec; 157(12):4754-4769. PubMed ID: 27690692
[TBL] [Abstract][Full Text] [Related]
27. FGF21 gene therapy as treatment for obesity and insulin resistance.
Jimenez V; Jambrina C; Casana E; Sacristan V; Muñoz S; Darriba S; Rodó J; Mallol C; Garcia M; León X; Marcó S; Ribera A; Elias I; Casellas A; Grass I; Elias G; Ferré T; Motas S; Franckhauser S; Mulero F; Navarro M; Haurigot V; Ruberte J; Bosch F
EMBO Mol Med; 2018 Aug; 10(8):. PubMed ID: 29987000
[TBL] [Abstract][Full Text] [Related]
28. Biological role, clinical significance, and therapeutic possibilities of the recently discovered metabolic hormone fibroblastic growth factor 21.
Iglesias P; Selgas R; Romero S; Díez JJ
Eur J Endocrinol; 2012 Sep; 167(3):301-9. PubMed ID: 22740503
[TBL] [Abstract][Full Text] [Related]
29. Association between insulin resistance and impairment of FGF21 signal transduction in skeletal muscles.
Jeon JY; Choi SE; Ha ES; Kim TH; Jung JG; Han SJ; Kim HJ; Kim DJ; Kang Y; Lee KW
Endocrine; 2016 Jul; 53(1):97-106. PubMed ID: 26758997
[TBL] [Abstract][Full Text] [Related]
30. The suppression of hepatic glucose production improves metabolism and insulin sensitivity in subcutaneous adipose tissue in mice.
Casteras S; Abdul-Wahed A; Soty M; Vulin F; Guillou H; Campana M; Le Stunff H; Pirola L; Rajas F; Mithieux G; Gautier-Stein A
Diabetologia; 2016 Dec; 59(12):2645-2653. PubMed ID: 27631137
[TBL] [Abstract][Full Text] [Related]
31. Fibroblast growth factor-21, energy balance and obesity.
Giralt M; Gavaldà-Navarro A; Villarroya F
Mol Cell Endocrinol; 2015 Dec; 418 Pt 1():66-73. PubMed ID: 26415590
[TBL] [Abstract][Full Text] [Related]
32. Hepatic insulin resistance and increased hepatic glucose production in mice lacking Fgf21.
Camporez JP; Asrih M; Zhang D; Kahn M; Samuel VT; Jurczak MJ; Jornayvaz FR
J Endocrinol; 2015 Sep; 226(3):207-17. PubMed ID: 26203166
[TBL] [Abstract][Full Text] [Related]
33. Fibroblast growth factor 21 as an emerging metabolic regulator: clinical perspectives.
Woo YC; Xu A; Wang Y; Lam KS
Clin Endocrinol (Oxf); 2013 Apr; 78(4):489-96. PubMed ID: 23134073
[TBL] [Abstract][Full Text] [Related]
34. Fibroblast growth factor 21 improves hepatic insulin sensitivity by inhibiting mammalian target of rapamycin complex 1 in mice.
Gong Q; Hu Z; Zhang F; Cui A; Chen X; Jiang H; Gao J; Chen X; Han Y; Liang Q; Ye D; Shi L; Chin YE; Wang Y; Xiao H; Guo F; Liu Y; Zang M; Xu A; Li Y
Hepatology; 2016 Aug; 64(2):425-38. PubMed ID: 26926384
[TBL] [Abstract][Full Text] [Related]
35. Combined effects of rosiglitazone and conjugated linoleic acid on adiposity, insulin sensitivity, and hepatic steatosis in high-fat-fed mice.
Liu LF; Purushotham A; Wendel AA; Belury MA
Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1671-82. PubMed ID: 17322064
[TBL] [Abstract][Full Text] [Related]
36. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
37. Abrogation of hepatic ATP-citrate lyase protects against fatty liver and ameliorates hyperglycemia in leptin receptor-deficient mice.
Wang Q; Jiang L; Wang J; Li S; Yu Y; You J; Zeng R; Gao X; Rui L; Li W; Liu Y
Hepatology; 2009 Apr; 49(4):1166-75. PubMed ID: 19177596
[TBL] [Abstract][Full Text] [Related]
38. Physiology and Endocrinology Symposium: FGF21: Insights into mechanism of action from preclinical studies.
Antonellis PJ; Kharitonenkov A; Adams AC
J Anim Sci; 2014 Feb; 92(2):407-13. PubMed ID: 24398833
[TBL] [Abstract][Full Text] [Related]
39. Alterations in regulation of energy homeostasis in cyclic nucleotide phosphodiesterase 3B-null mice.
Choi YH; Park S; Hockman S; Zmuda-Trzebiatowska E; Svennelid F; Haluzik M; Gavrilova O; Ahmad F; Pepin L; Napolitano M; Taira M; Sundler F; Stenson Holst L; Degerman E; Manganiello VC
J Clin Invest; 2006 Dec; 116(12):3240-51. PubMed ID: 17143332
[TBL] [Abstract][Full Text] [Related]
40. Ghrelin enhances in vivo skeletal muscle but not liver AKT signaling in rats.
Barazzoni R; Zanetti M; Cattin MR; Visintin L; Vinci P; Cattin L; Stebel M; Guarnieri G
Obesity (Silver Spring); 2007 Nov; 15(11):2614-23. PubMed ID: 18070752
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
